YAUPON THERAPEUTICS

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Employees
-
Market Cap
-
Website

Effectiveness of Lobeline in Treating Symptoms of ADHD in Adult Patients

First Posted Date
2008-04-23
Last Posted Date
2013-06-20
Lead Sponsor
Yaupon Therapeutics
Target Recruit Count
13
Registration Number
NCT00664703
Locations
๐Ÿ‡บ๐Ÿ‡ธ

General Clinical Research Center, University of Kentucky, Lexington, Kentucky, United States

An Open Label Study to Evaluate the Safety and Efficacy of Mechlorethamine(MCH) 0.04% Formulation in Mycosis Fungoides

Phase 2
Completed
Conditions
Interventions
First Posted Date
2007-09-26
Last Posted Date
2012-08-09
Lead Sponsor
Yaupon Therapeutics
Target Recruit Count
100
Registration Number
NCT00535470
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States

๐Ÿ‡บ๐Ÿ‡ธ

Stanford University Medical Center, Stanford, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

Columbia University, Dept of Dermatology, New York, New York, United States

and more 8 locations

Safety and Efficacy of Nitrogen Mustard in Treatment of Mycosis Fungoides

First Posted Date
2005-09-14
Last Posted Date
2012-10-31
Lead Sponsor
Yaupon Therapeutics
Target Recruit Count
260
Registration Number
NCT00168064
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of Texas, Southwestern Medical Center, Dallas, Texas, United States

๐Ÿ‡บ๐Ÿ‡ธ

Northwestern University - Dept. of Dermatology, Chicago, Illinois, United States

๐Ÿ‡บ๐Ÿ‡ธ

Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States

and more 9 locations
ยฉ Copyright 2024. All Rights Reserved by MedPath